• Adya R, Tan BK, Punn A, Chen J, Randeva HS. 2008. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc Res 78:356365.
  • Bruix J, Sherman M. 2011. Management of hepatocellular carcinoma: an update. Hepatology 53:10201022.
  • Carnevale D, Cifelli G, Mascio G, Madonna M, Sbroggiò M, Perrino C, Persico MG, Frati G, Lembo G. 2011. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-α-converting enzyme axis: crucial role for adaptive cardiac remodeling during cardiac pressure overload. Circulation 124:13371350.
  • Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J, Zhang LJ. 2009. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res 39:177186.
  • Dallas MR, Liu G, Chen WC, Thomas SN, Wirtz D, Huso DL, Konstantopoulos K. 2010. CD44, a therapeutic target for metastasizing tumours. Eur J Cancer 46:12711277.
  • Dallas MR, Liu G, Chen WC, Thomas SN, Wirtz D, Huso DL, Konstantopoulos K. 2012. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. FASEB J 26:26482656.
  • Forough R, Weylie B, Collins C, Parker JL, Zhu J, Barhoumi R, Watson DK. 2006. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo: role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway. J Vasc Res 43:327337.
  • Gaud G, Iochmann S, Guillon-Munos A, Brillet B, Petiot S, Seigneuret F, Touzé A, Heuzé-Vourc'h N, Courty Y, Lerondel S, Gruel Y, Reverdiau P. 2011. TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions. J Cell Mol Med 15:196208.
  • Iochmann S, Bléchet C, Chabot V, Saulnier A, Amini A, Gaud G, Gruel Y, Reverdiau P. 2009. Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion. Clin Exp Metastasis 26:457497.
  • Jung CW, Song TJ, Lee KO, Choi SB, Kim WB, Suh SO, Kim YC, Choi SY. 2012. Charaterization of hepatocellular carcinoma cell lines based on cell adhesion molecules. Int J Mol Med 29:11581164.
  • Katunina AI, Gershtein ES, Ermilova VD, Tereshkina IV, Nazarenko AY, Tyleuova AA, Dvorova EK, Karabekova ZK, Gritskevich MV, Berezov TT. 2011. Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer. Bull Exp Biol Med 151:359362.
  • Kinjo T, Ye J, Yan H, Hamasaki T, Nakanishi H, Toh K, Nakamichi N, Kabayama S, Teruya K, Shirahata S. 2012. Suppressive effects of electrochemically reduced water on matrix metalloproteinase-2 activities and in vitro invasion of human fibrosarcoma HT1080 cells. Cytotechnology 64:357371.
  • Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. 2001. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630636.
  • Nordenstedt H, White DL, El-Serag HB. 2010. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42:S206S214.
  • Oh JH, Kim A, Park JM, Kim SH, Chung AS. 2006. Ultraviolet B-induced matrix metalloproteinase-1 and −3 secretions are mediated via PTEN/Akt pathway in human dermal fibroblasts. J Cell Physiol 209:775785.
  • Oiso S, Ikeda R, Nakamura K, Takeda Y, Akiyama S, Kariyazono H. 2012. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells. Oncol Rep 28:2732.
  • Sierko E, Wojtukiewicz MZ, Kisiel W. 2007. The role of tissue factor pathway inhibitor-2 in cancer biology. Semin Thromb Hemos 33:653659.
  • Wang X, Ling C, Bai Y, Zhao J. 2011. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec 294:8892.
  • Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO. 2007. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 45:11291138.
  • Yang Q, Ye ZY, Zhang JX, Tao HQ, Li SG, Zhao ZS. 2010. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Anat Rec 293:20122019.
  • Zöller M. 2011. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11:254267.